Table 6.

Crude and adjusted HRs with 95% CIs for mortality related to clinical parameters and fatty acid oxidation-related expression of enzymes. Stage III/IV case (n = 79).

Factor	Crude HR (95% CI)	p-Value	Adjusted HR (95% CI)	p-Value
Age, per 10 years	1.53 (1.10–2.12)	0.012 *	1.59 (1.10–2.29)	0.014 *
Pretreatment fasting sugar: ≥100 vs. <100 mg/dL	0.95 (0.45–1.99)	0.885	0.72 (0.33–1.56)	0.401
FAS: 2~3+ vs. 0~1+	0.17 (0.02–1.21)	0.077	0.15 (0.02–1.13)	0.066
MCAD: 3+ vs. 0~2+	1.34 (0.64–2.82)	0.439	1.36 (0.64–2.90)	0.431
LCAD: 2~3+ vs. 0~1+	0.28 (0.07–1.18)	0.084	0.21 (0.05–0.91)	0.037 *
VLCAD: 2~3+ vs. 0~1+	1.46 (0.59–3.60)	0.415	1.41 (0.54–3.64)	0.483
HADHA: 3+ vs. 0~2+	1.44 (0.55–3.80)	0.460	0.80 (0.29–2.20)	0.668

VIF values: Age: 1.33, Pretreatment fasting sugar: 1.08, FAS: 1.34, MCAD: 1.60, LCAD: 1.29, VLCAD: 1.09, HADHA: 1.18. * p < 0.05.